Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib versus naproxen or no treatment in end-stage knee osteoarthritis before total knee replacement
NL-OMON25692Recruiting
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Dec 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of celecoxib and Aprol in knee osteoarthritis (OA) (4 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Proteoglycan release from osteoarthritic cartilage. Started Dec 2007; status: recruiting.
02
Drugs
celecoxibAprol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON25692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25692.